Sichuan Kelun Pharmaceutical Co Ltd (002422) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥537.31 Million ≈ $78.62 Million USD) by net assets (CN¥28.62 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sichuan Kelun Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Sichuan Kelun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sichuan Kelun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002422 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Bluescope Steel Ltd
AU:BSL
0.069x
Pandora A/S
CO:PNDORA
0.010x
Solstice Advanced Materials, Inc
NASDAQ:SOLS
0.165x
OGE Energy Corporation
NYSE:OGE
-0.003x
Autoliv Inc
ST:ALIV-SDB
-0.028x
Konfoong Materials International Co Ltd
SHE:300666
0.018x
Brinker International Inc
NYSE:EAT
0.572x
Rexel S.A
PA:RXL
0.147x

Annual Cash Flow Conversion Efficiency for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. View Sichuan Kelun Pharmaceutical Co Ltd (002422) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥29.29 Billion
≈ $4.29 Billion
CN¥2.64 Billion
≈ $386.62 Million
0.090x -46.32%
2024-12-31 CN¥26.74 Billion
≈ $3.91 Billion
CN¥4.49 Billion
≈ $657.45 Million
0.168x -27.54%
2023-12-31 CN¥23.02 Billion
≈ $3.37 Billion
CN¥5.34 Billion
≈ $780.98 Million
0.232x +25.09%
2022-12-31 CN¥16.87 Billion
≈ $2.47 Billion
CN¥3.13 Billion
≈ $457.65 Million
0.185x -8.00%
2021-12-31 CN¥14.13 Billion
≈ $2.07 Billion
CN¥2.85 Billion
≈ $416.62 Million
0.202x +27.14%
2020-12-31 CN¥14.00 Billion
≈ $2.05 Billion
CN¥2.22 Billion
≈ $324.77 Million
0.158x -0.58%
2019-12-31 CN¥13.91 Billion
≈ $2.03 Billion
CN¥2.22 Billion
≈ $324.38 Million
0.159x -30.12%
2018-12-31 CN¥12.95 Billion
≈ $1.89 Billion
CN¥2.95 Billion
≈ $432.19 Million
0.228x +127.17%
2017-12-31 CN¥11.98 Billion
≈ $1.75 Billion
CN¥1.20 Billion
≈ $176.06 Million
0.100x -33.27%
2016-12-31 CN¥11.47 Billion
≈ $1.68 Billion
CN¥1.73 Billion
≈ $252.48 Million
0.150x +35.54%
2015-12-31 CN¥11.16 Billion
≈ $1.63 Billion
CN¥1.24 Billion
≈ $181.37 Million
0.111x -0.06%
2014-12-31 CN¥10.97 Billion
≈ $1.61 Billion
CN¥1.22 Billion
≈ $178.34 Million
0.111x +6.02%
2013-12-31 CN¥10.02 Billion
≈ $1.47 Billion
CN¥1.05 Billion
≈ $153.70 Million
0.105x +135.82%
2012-12-31 CN¥9.06 Billion
≈ $1.33 Billion
CN¥402.77 Million
≈ $58.94 Million
0.044x +2.77%
2011-12-31 CN¥7.93 Billion
≈ $1.16 Billion
CN¥342.93 Million
≈ $50.18 Million
0.043x +104.24%
2010-12-31 CN¥7.05 Billion
≈ $1.03 Billion
CN¥149.29 Million
≈ $21.85 Million
0.021x -86.66%
2009-12-31 CN¥1.58 Billion
≈ $231.12 Million
CN¥250.69 Million
≈ $36.68 Million
0.159x -14.55%
2008-12-31 CN¥1.19 Billion
≈ $174.17 Million
CN¥221.08 Million
≈ $32.35 Million
0.186x -23.77%
2007-12-31 CN¥691.22 Million
≈ $101.15 Million
CN¥168.42 Million
≈ $24.65 Million
0.244x --

About Sichuan Kelun Pharmaceutical Co Ltd

SHE:002422 China Drug Manufacturers - General
Market Cap
$9.67 Billion
CN¥66.08 Billion CNY
Market Cap Rank
#2308 Global
#248 in China
Share Price
CN¥41.54
Change (1 day)
-0.91%
52-Week Range
CN¥28.83 - CN¥51.35
All Time High
CN¥51.35
About

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more